Lixarkitug (AZD9829 antibody, INT-020) is a humanized IgG1kappa antibody targeting IL-3Ra/CD123. Lixarkitug can be conjugated with Samrotecan to form the intact ADC molecule lixarkitug samrotecan (AZD9829), which is used in studies of acute myeloid leukemia (AML)[1][2]. The isotype control corresponding to Lixarkitug is Human IgG1 kappa, Isotype Control (HY-P99001).
Molekulargewicht:
(146.147 kDa)
Reinheit:
99
CAS Nummer:
[3035710-69-8]
Target-Kategorie:
ADC Antibody,Interleukin Related
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten